Zhiping Yan

3.1k total citations
88 papers, 2.0k citations indexed

About

Zhiping Yan is a scholar working on Hepatology, Surgery and Cancer Research. According to data from OpenAlex, Zhiping Yan has authored 88 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hepatology, 28 papers in Surgery and 22 papers in Cancer Research. Recurrent topics in Zhiping Yan's work include Hepatocellular Carcinoma Treatment and Prognosis (31 papers), Liver Disease Diagnosis and Treatment (18 papers) and Liver Disease and Transplantation (16 papers). Zhiping Yan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (31 papers), Liver Disease Diagnosis and Treatment (18 papers) and Liver Disease and Transplantation (16 papers). Zhiping Yan collaborates with scholars based in China, United States and Ethiopia. Zhiping Yan's co-authors include Jianjun Luo, Ye Zeng, Xiaoheng Liu, Jianhua Wang, Yi Chen, Xiaolin Wang, Xinghong Yao, Minjie Yang, Jingxia Liu and Daqiao Guo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Zhiping Yan

81 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiping Yan China 24 876 661 506 420 387 88 2.0k
Shinya Hayami Japan 28 1.7k 2.0× 424 0.6× 492 1.0× 380 0.9× 639 1.7× 101 2.9k
Liping Zhuang China 21 690 0.8× 617 0.9× 277 0.5× 223 0.5× 244 0.6× 51 1.9k
Francesco Vasuri Italy 22 469 0.5× 303 0.5× 231 0.5× 512 1.2× 424 1.1× 125 1.5k
Eric T. Kimchi United States 27 588 0.7× 382 0.6× 504 1.0× 237 0.6× 440 1.1× 103 2.1k
Yunpeng Hua China 23 429 0.5× 311 0.5× 323 0.6× 388 0.9× 370 1.0× 53 1.6k
Michele Quaranta Italy 24 596 0.7× 457 0.7× 198 0.4× 205 0.5× 202 0.5× 57 1.6k
Klaus J. Schmitz Germany 22 514 0.6× 297 0.4× 261 0.5× 184 0.4× 425 1.1× 51 1.4k
Yongxiang Xia China 23 765 0.9× 519 0.8× 254 0.5× 204 0.5× 336 0.9× 56 1.9k
Rossella Rota Italy 27 1.2k 1.3× 310 0.5× 306 0.6× 189 0.5× 146 0.4× 79 1.8k
David Ho Hong Kong 21 1.0k 1.2× 643 1.0× 154 0.3× 607 1.4× 327 0.8× 35 2.3k

Countries citing papers authored by Zhiping Yan

Since Specialization
Citations

This map shows the geographic impact of Zhiping Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiping Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiping Yan more than expected).

Fields of papers citing papers by Zhiping Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiping Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiping Yan. The network helps show where Zhiping Yan may publish in the future.

Co-authorship network of co-authors of Zhiping Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiping Yan. A scholar is included among the top collaborators of Zhiping Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiping Yan. Zhiping Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhifang, et al.. (2025). Tomato mitogen-activated protein kinase: mechanisms of adaptation in response to biotic and abiotic stresses. Frontiers in Plant Science. 16. 1533248–1533248. 3 indexed citations
2.
Fan, Zhuoyang, Guowei Yang, Rongkui Luo, et al.. (2024). Sublethal heat treatment enhances lactic acid uptake in macrophages via MCT1, leading to reduced paraspeckle formation and a subsequent decrease in macrophage pyroptosis. Frontiers in Immunology. 14. 1290185–1290185. 4 indexed citations
3.
Shi, Qin, Peng Huang, Zihan Zhang, et al.. (2023). Hepatocellular Carcinoma with Radiological Progression: Lenvatinib Plus PD-1 Inhibitor Combined with Microwave Ablation and Synchronous Transarterial Chemoembolization. Journal of Hepatocellular Carcinoma. Volume 10. 1861–1871. 1 indexed citations
4.
5.
Zhou, Yongjie, Tianzhu Yu, Wen Zhang, et al.. (2023). Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction. Thrombosis Journal. 21(1). 6–6. 2 indexed citations
6.
Gao, Shanshan, Mengfei Wu, Yi Chen, et al.. (2023). The prognostic role of the AST/ALT ratio in hepatocellular carcinoma patients receiving thermal ablation combined with simultaneous TACE. BMC Gastroenterology. 23(1). 80–80. 8 indexed citations
7.
Yang, Minjie, Sen Jiang, Yanli Wang, et al.. (2023). Chinese expert consensus on transradial access in percutaneous peripheral interventions. SHILAP Revista de lepidopterología. 6(4). 145–152. 2 indexed citations
8.
Zhong, Bin‐Yan, Zhiping Yan, Junhui Sun, et al.. (2021). Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib. Frontiers in Molecular Biosciences. 8. 618050–618050. 8 indexed citations
9.
Tseng, Yujen, Minzhi Lv, Tiancheng Luo, et al.. (2020). The role of a multidisciplinary team in the management of portal hypertension. BMC Gastroenterology. 20(1). 83–83. 2 indexed citations
10.
Yang, Minjie, Jingqin Ma, Jianjun Luo, et al.. (2019). Transradial access chemoembolization for hepatocellular carcinoma in comparation with transfemoral access. Translational Cancer Research. 8(5). 1795–1805. 2 indexed citations
11.
Zhang, Wei, Sheng Qian, Guowei Yang, et al.. (2018). MicroRNA-199 suppresses cell proliferation, migration and invasion by downregulating RGS17 in hepatocellular carcinoma. Gene. 659. 22–28. 36 indexed citations
12.
Xu, Xiaoqing, Tian Hong, Jun Huang, et al.. (2016). The interplay between HPIP and casein kinase 1α promotes renal cell carcinoma growth and metastasis via activation of mTOR pathway. Oncogenesis. 5(10). e260–e260. 18 indexed citations
13.
Wang, Guangzhi, Sheng Qian, Xu-Dong Qu, et al.. (2016). Combination Therapies in the Management of Large (≥ 5 cm) Hepatocellular Carcinoma: Microwave Ablation Immediately Followed by Transarterial Chemoembolization. Journal of Vascular and Interventional Radiology. 27(10). 1577–1583. 23 indexed citations
14.
Yang, Minjie, Zhiping Yan, Jianjun Luo, et al.. (2016). A pilot study of intraluminal brachytherapy using 125I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice. Brachytherapy. 15(6). 859–864. 25 indexed citations
15.
Zeng, Ye, Xinghong Yao, Zhiping Yan, Jingxia Liu, & Xiaoheng Liu. (2016). Potential signaling pathway involved in sphingosine-1-phosphate-induced epithelial-mesenchymal transition in cancer. Oncology Letters. 12(1). 379–382. 26 indexed citations
16.
Yang, Guowei, Qing Zhao, Liang Zhu, et al.. (2015). Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for the treatment of advanced intrahepatic cholangiocarcinoma. OncoTargets and Therapy. 8. 1245–1245. 24 indexed citations
17.
Wang, Jing, Zhiping Yan, Xu Qian, et al.. (2012). MiR-128 Inhibits Tumor Growth and Angiogenesis by Targeting p70S6K1. PLoS ONE. 7(3). e32709–e32709. 128 indexed citations
18.
19.
Chen, Yi, Xiaolin Wang, Jianhua Wang, Zhiping Yan, & Jianjun Luo. (2012). Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies. European Journal of Cancer. 48(14). 2137–2145. 192 indexed citations
20.
Chen, Yi, Xiaolin Wang, Zhiping Yan, et al.. (2011). The Use of 125 I Seed Strands for Intraluminal Brachytherapy of Malignant Obstructive Jaundice. Cancer Biotherapy and Radiopharmaceuticals. 27(5). 317–323. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinya Hayami Breakdown of academic impact, for papers by Liping Zhuang Breakdown of academic impact, for papers by Francesco Vasuri Breakdown of academic impact, for papers by Eric T. Kimchi Breakdown of academic impact, for papers by Yunpeng Hua Breakdown of academic impact, for papers by Michele Quaranta Breakdown of academic impact, for papers by Klaus J. Schmitz Breakdown of academic impact, for papers by Yongxiang Xia Breakdown of academic impact, for papers by Rossella Rota Breakdown of academic impact, for papers by David Ho
Rankless by CCL
2026